GEODE CAPITAL MANAGEMENT, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$27,702,632
-28.2%
1,726,884
+3.7%
0.00%
-40.0%
Q2 2023$38,591,168
+3.6%
1,664,847
+3.8%
0.01%0.0%
Q1 2023$37,263,421
+168223.3%
1,604,107
+5.1%
0.01%
+66.7%
Q4 2022$22,138
-99.9%
1,525,774
+3.7%
0.00%
-25.0%
Q3 2022$28,062,000
+6.9%
1,470,770
+1.8%
0.00%0.0%
Q2 2022$26,260,000
-28.0%
1,445,292
-0.2%
0.00%
-20.0%
Q1 2022$36,488,000
-7.5%
1,447,957
+1.3%
0.01%0.0%
Q4 2021$39,442,000
-11.5%
1,429,078
+3.6%
0.01%
-16.7%
Q3 2021$44,551,000
+6.8%
1,379,716
+1.2%
0.01%0.0%
Q2 2021$41,703,000
+8.4%
1,363,765
+7.9%
0.01%0.0%
Q1 2021$38,478,000
+70.1%
1,263,677
+10.5%
0.01%
+50.0%
Q4 2020$22,621,000
+54.5%
1,143,966
+1.9%
0.00%
+33.3%
Q3 2020$14,642,000
+12.7%
1,122,874
-2.0%
0.00%0.0%
Q2 2020$12,991,000
-17.8%
1,145,701
+3.7%
0.00%
-25.0%
Q1 2020$15,807,000
-72.5%
1,104,626
-47.6%
0.00%
-33.3%
Q4 2019$57,376,000
+98.4%
2,107,106
+108.6%
0.01%
-14.3%
Q3 2019$28,915,000
+4.3%
1,009,982
+1.2%
0.01%0.0%
Q2 2019$27,736,000
-9.9%
998,443
+7.7%
0.01%
-12.5%
Q1 2019$30,768,000
-39.8%
926,773
-47.3%
0.01%0.0%
Q4 2018$51,130,000
+43.3%
1,758,898
+126.7%
0.01%
-20.0%
Q3 2018$35,692,000
+30.3%
775,921
+5.9%
0.01%
+25.0%
Q2 2018$27,392,000
+37.1%
733,021
+8.4%
0.01%
+14.3%
Q1 2018$19,983,000
-5.7%
676,259
+9.6%
0.01%0.0%
Q4 2017$21,183,000
-11.2%
616,796
-6.5%
0.01%
-22.2%
Q3 2017$23,858,000
+41.2%
659,427
+0.8%
0.01%
+28.6%
Q2 2017$16,896,000
+33.1%
653,875
-1.1%
0.01%
+40.0%
Q1 2017$12,696,000
+18.6%
661,307
+3.0%
0.01%0.0%
Q4 2016$10,702,000
-16.6%
642,056
+3.0%
0.01%
-16.7%
Q3 2016$12,833,000
-25.2%
623,628
+11.2%
0.01%
-33.3%
Q2 2016$17,166,000
-13.1%
561,028
+6.3%
0.01%
-10.0%
Q1 2016$19,747,000
-6.6%
527,592
+7.7%
0.01%
-16.7%
Q4 2015$21,137,000
+16.8%
489,750
+1.5%
0.01%
+9.1%
Q3 2015$18,090,000
+16.7%
482,658
+5.8%
0.01%
+22.2%
Q2 2015$15,501,000
+9.1%
456,069
+13.6%
0.01%
+12.5%
Q1 2015$14,212,000
+6.1%
401,479
+2.1%
0.01%0.0%
Q4 2014$13,396,000
-10.4%
393,312
+1.4%
0.01%
-20.0%
Q3 2014$14,958,000
-0.0%
387,830
+0.9%
0.01%0.0%
Q2 2014$14,961,000
+16.8%
384,405
+2.6%
0.01%
+11.1%
Q1 2014$12,805,000
+62.4%
374,547
-0.4%
0.01%
+80.0%
Q4 2013$7,886,000
-31.8%
375,960
-23.6%
0.01%
-44.4%
Q3 2013$11,569,000
-6.4%
492,306
+7.0%
0.01%
-18.2%
Q2 2013$12,359,000459,9710.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders